SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-013137
Filing Date
2023-09-11
Accepted
2023-09-11 09:15:13
Documents
1
Period of Report
2023-08-30

Document Format Files

Seq Description Document Type Size
1 form4-09112023_010907.html 4  
1 form4-09112023_010907.xml 4 5388
  Complete submission text file 0001415889-23-013137.txt   6905
Mailing Address C/O GALMED PHARMACEUTICALS LTD., 8 SHAUL HAMELECH BLVD, AMOT HAMISHPAT BLDG. TEL AVIV L3 64733
Business Address
Hurvitz Chaim (Reporting) CIK: 0001630542 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38302 | Film No.: 231246952

Mailing Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801
Business Address 1201 ORANGE STREET SUITE 600 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Issuer) CIK: 0001719406 (see all company filings)

IRS No.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations